These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29206496)

  • 61. Investigation and correlation of drug polymer miscibility and molecular interactions by various approaches for the preparation of amorphous solid dispersions.
    Meng F; Trivino A; Prasad D; Chauhan H
    Eur J Pharm Sci; 2015 Apr; 71():12-24. PubMed ID: 25686597
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evaluation of solid dispersions of Clofazimine.
    Narang AS; Srivastava AK
    Drug Dev Ind Pharm; 2002 Sep; 28(8):1001-13. PubMed ID: 12378955
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Tri-block polymer with interfacial layer formation ability and its use in maintaining supersaturated drug solution after dissolution of solid dispersions.
    Fu JJ; Liu CC
    Int J Nanomedicine; 2018; 13():1611-1619. PubMed ID: 29588588
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Formation and characterization of solid dispersions of piroxicam and polyvinylpyrrolidone using spray drying and precipitation with compressed antisolvent.
    Wu K; Li J; Wang W; Winstead DA
    J Pharm Sci; 2009 Jul; 98(7):2422-31. PubMed ID: 18972575
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The Influence of the Strength of Drug-Polymer Interactions on the Dissolution of Amorphous Solid Dispersions.
    Amponsah-Efah KK; Mistry P; Eisenhart R; Suryanarayanan R
    Mol Pharm; 2021 Jan; 18(1):174-186. PubMed ID: 33332132
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
    Fini A; Cavallari C; Ospitali F
    Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Preparation, physicochemical characterization and drug release studies of albendazole solid dispersions.
    Mallick S; Sahoo A; Mitra SS
    Boll Chim Farm; 2003 May; 142(4):180-6. PubMed ID: 12918228
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antisolvent precipitation technique: A very promising approach to crystallize curcumin in presence of polyvinyl pyrrolidon for solubility and dissolution enhancement.
    Sadeghi F; Ashofteh M; Homayouni A; Abbaspour M; Nokhodchi A; Garekani HA
    Colloids Surf B Biointerfaces; 2016 Nov; 147():258-264. PubMed ID: 27518458
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Dissolution kinetics for coprecipitates of diflunisal with PVP K30.
    Rodríguez-Espinosa C; Martínez-Ohárriz MC; Martín C; Goñi MM; Vélaz I; Sánchez M
    Eur J Drug Metab Pharmacokinet; 1998; 23(2):109-12. PubMed ID: 9725466
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Solid dispersions of telaprevir with improved solubility prepared by co-milling: formulation, physicochemical characterization, and cytotoxicity evaluation.
    Xiong X; Zhang M; Hou Q; Tang P; Suo Z; Zhu Y; Li H
    Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110012. PubMed ID: 31546459
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Physicochemical characterization and dissolution study of solid dispersions of diacerein with polyethylene glycol 6000.
    Aggarwal AK; Singh S
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1181-91. PubMed ID: 21449824
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Bilayer Tablet Formulation of Metformin HCl and Acarbose: A Novel Approach To Control Diabetes.
    Tiwari R; Gupta A; Joshi M; Tiwari G
    PDA J Pharm Sci Technol; 2014; 68(2):138-52. PubMed ID: 24668601
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Solubilization and interaction of sulindac with polyvinylpyrrolidone K30 in the solid state and in aqueous solution.
    Tros de Ilarduya MC; Martín C; Goñi MM; Martínez-Ohárriz MC
    Drug Dev Ind Pharm; 1998 Mar; 24(3):295-300. PubMed ID: 9876588
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Development and physicochemical characterization of saquinavir mesylate solid dispersions using Gelucire 44/14 or PEG 4000 as carrier.
    Caon T; Konig RA; da Cruz AC; Cardoso SG; Campos CE; Cuffini SL; Koester LS; Simões CM
    Arch Pharm Res; 2013 Sep; 36(9):1113-25. PubMed ID: 23700292
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Solid state and dissolution rate characterization of co-ground mixtures of nifedipine and hydrophilic carriers.
    Friedrich H; Nada A; Bodmeier R
    Drug Dev Ind Pharm; 2005 Sep; 31(8):719-28. PubMed ID: 16221606
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Physicochemical characterization of solid dispersions of three antiepileptic drugs prepared by solvent evaporation method.
    Douroumis D; Bouropoulos N; Fahr A
    J Pharm Pharmacol; 2007 May; 59(5):645-53. PubMed ID: 17524229
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Design of mirtazapine solid dispersion with different carriers' systems: optimization, in vitro evaluation, and bioavailability assessment.
    Aldeeb RAE; Mahdy MAE; El-Nahas HM; Musallam AA
    Drug Deliv Transl Res; 2023 Sep; 13(9):2340-2352. PubMed ID: 36940079
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Tablet Formulation of a Polymeric Solid Dispersion Containing Amorphous Alkalinized Telmisartan.
    Chae JS; Chae BR; Shin DJ; Goo YT; Lee ES; Yoon HY; Kim CH; Choi YW
    AAPS PharmSciTech; 2018 Oct; 19(7):2990-2999. PubMed ID: 30043191
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Dissolution rate of furosemide from polyethylene glycol solid dispersions.
    Ozdemir N; Ordu S
    Farmaco; 1997 Oct; 52(10):625-9. PubMed ID: 9507675
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Solid dispersions of diflunisal-PVP: polymorphic and amorphous states of the drug.
    Martínez-Ohárriz MC; Rodríguez-Espinosa C; Martín C; Goñi MM; Tros-Ilarduya MC; Sánchez M
    Drug Dev Ind Pharm; 2002 Jul; 28(6):717-25. PubMed ID: 12149965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.